{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:46:45Z","timestamp":1787928405147,"version":"build-2784847793"},"reference-count":38,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"unspecified","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Academisch Medisch Centrum 2020","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"crossref","award":["2016-10781"],"award-info":[{"award-number":["2016-10781"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,7,18]]},"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Anal cancer precursors, or high-grade anal intraepithelial neoplasia (HGAIN), are highly prevalent in HIV-seropositive (HIV+) men who have sex with men (MSM). Around 30% of lesions regress within 1\u2009year, but current histopathological assessment is unable to distinguish between HGAIN likely to regress and HGAIN likely to persist or progress to cancer. We aim to assess if host cell DNA methylation markers can predict regression of HGAIN, thus determining the need for immediate treatment or active surveillance. This could reduce overtreatment and the associated anal and psycho-sexual morbidity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>This is an active surveillance cohort study in three centres located in Amsterdam, the Netherlands, in 200 HIV+ MSM diagnosed with HGAIN. Participants will not be treated, but closely monitored during 24\u2009months of follow-up with 6\u2009monthly visits including cytology, and high-resolution anoscopy with biopsies. The primary study endpoint is histopathological regression of each baseline HGAIN lesion at the end of the study. Regression is defined as \u2264low grade anal intraepithelial neoplasia in the exit biopsy at 24 months. Regression proportions in lesions with low versus high methylation levels (<jats:italic>ASCL1<\/jats:italic>, <jats:italic>ZNF582<\/jats:italic>), other biomarkers (HPV genotype, HPV-E4, p16<jats:sup>INK4A<\/jats:sup>, Ki-67) and immunological markers at baseline will be compared. Main secondary endpoints are the histological and clinical outcome (ie, the number of octants affected by HGAIN) of each baseline HGAIN lesion and overall HGAIN disease (i.e., all lesions combined) after each visit. The health-related quality of life of the study group will be compared with that of a control group of 50 HIV+ MSM receiving regular HGAIN treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>Ethics approval was obtained from the Institutional Review Board of the Academic Medical Center (Amsterdam, The Netherlands; reference no. 2021_099). Participants are required to provide written informed consent. Findings will be disseminated through publication in peer-reviewed scientific journals and presentations at international scientific conferences; dissemination to policy makers and the target patient group will be achieved through our (inter-)national network, professional associations and collaboration with a patient representative organisation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>NL9664.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-060301","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T11:42:41Z","timestamp":1659526961000},"page":"e060301","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["DNA Methylation Analysis to predict Regression of high-grade anal Intraepithelial Neoplasia in HIV+ men (MARINE): a cohort study protocol"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0546-7956","authenticated-orcid":false,"given":"Fernando","family":"Dias Gon\u00e7alves Lima","sequence":"first","affiliation":[{"name":"Department of Dermatology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands"},{"name":"Department of Pathology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands"},{"name":"Amsterdam Institute for Infection and Immunology, Amsterdam UMC Location AMC, Amsterdam, The Netherlands"},{"name":"Cancer Center Amsterdam, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1325-1901","authenticated-orcid":false,"given":"Ramon P","family":"van der Zee","sequence":"additional","affiliation":[{"name":"Department of Pathology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands"},{"name":"Amsterdam Institute for Infection and Immunology, Amsterdam UMC Location AMC, Amsterdam, The Netherlands"},{"name":"Cancer Center Amsterdam, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e8fanie","family":"Dick","sequence":"additional","affiliation":[{"name":"Department of Pathology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands"},{"name":"Cancer Center Amsterdam, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel J M","family":"van Noesel","sequence":"additional","affiliation":[{"name":"Department of Pathology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands"},{"name":"Cancer Center Amsterdam, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Berkhof","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Data Science, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten F","family":"Schim van der Loeff","sequence":"additional","affiliation":[{"name":"Amsterdam Institute for Infection and Immunology, Amsterdam UMC Location AMC, Amsterdam, The Netherlands"},{"name":"Department of Research, Public Health Service Amsterdam, Cluster Infectious Diseases, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M","family":"Prins","sequence":"additional","affiliation":[{"name":"Amsterdam Institute for Infection and Immunology, Amsterdam UMC Location AMC, Amsterdam, The Netherlands"},{"name":"Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske D M","family":"Steenbergen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands"},{"name":"Cancer Center Amsterdam, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J C","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands"},{"name":"Amsterdam Institute for Infection and Immunology, Amsterdam UMC Location AMC, Amsterdam, The Netherlands"},{"name":"Department of Research, Public Health Service Amsterdam, Cluster Infectious Diseases, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"2025101811104129000_12.8.e060301.1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ijc.33185","article-title":"A meta-analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale","volume":"148","author":"Clifford","year":"2021","journal-title":"Int J Cancer"},{"key":"2025101811104129000_12.8.e060301.2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24215"},{"key":"2025101811104129000_12.8.e060301.3","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0b013e31825c31dd"},{"key":"2025101811104129000_12.8.e060301.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70080-3"},{"key":"2025101811104129000_12.8.e060301.5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/LGT.0000000000000256","article-title":"2016 IANS international guidelines for practice standards in the detection of anal cancer precursors","volume":"20","author":"Hillman","year":"2016","journal-title":"J Low Genit Tract Dis"},{"key":"2025101811104129000_12.8.e060301.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70067-6"},{"key":"2025101811104129000_12.8.e060301.7","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2201048","article-title":"Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer","volume":"386","author":"Palefsky","year":"2022","journal-title":"N Engl J Med"},{"key":"2025101811104129000_12.8.e060301.8","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/ciaa166","article-title":"The natural history of anal high-grade squamous intraepithelial lesions in gay and bisexual men","volume":"72","author":"Poynten","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025101811104129000_12.8.e060301.9","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/cid\/ciy615","article-title":"A randomized clinical trial of infrared coagulation ablation versus active monitoring of intra-anal high-grade dysplasia in adults with human immunodeficiency virus infection: an AIDS malignancy Consortium trial","volume":"68","author":"Goldstone","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025101811104129000_12.8.e060301.10","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283633111"},{"key":"2025101811104129000_12.8.e060301.11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/DCR.0000000000000511","article-title":"Health-related quality of life and sexual functioning of HIV-positive men who have sex with men who are treated for anal intraepithelial neoplasia","volume":"59","author":"Siegenbeek van Heukelom","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"2025101811104129000_12.8.e060301.12","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3728"},{"key":"2025101811104129000_12.8.e060301.13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3615"},{"key":"2025101811104129000_12.8.e060301.14","doi-asserted-by":"crossref","first-page":"125.e1","DOI":"10.1016\/j.cmi.2020.03.018","article-title":"FAM19A4\/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort","volume":"27","author":"Vink","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2025101811104129000_12.8.e060301.15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2019.06.002","article-title":"Long-Term CIN3+ risk of HPV positive women after triage with FAM19A4\/miR124-2 methylation analysis","volume":"154","author":"Dick","year":"2019","journal-title":"Gynecol Oncol"},{"key":"2025101811104129000_12.8.e060301.16","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-14-0237"},{"key":"2025101811104129000_12.8.e060301.17","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/cid\/ciz677","article-title":"Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia","volume":"70","author":"Louvanto","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025101811104129000_12.8.e060301.18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.33320","article-title":"Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: a large European multicenter study","volume":"148","author":"Bonde","year":"2021","journal-title":"Int J Cancer"},{"key":"2025101811104129000_12.8.e060301.19","article-title":"Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4\/miR124-2 DNA Methylation (CONCERVE Study)","author":"Kremer","year":"2022","journal-title":"J Clin Oncol"},{"key":"2025101811104129000_12.8.e060301.20","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ijc.31539","article-title":"Cervical cancer risk in HPV-positive women after a negative FAM19A4\/mir124-2 methylation test: a post hoc analysis in the POBASCAM trial with 14 year follow-up","volume":"143","author":"De Strooper","year":"2018","journal-title":"Int J Cancer"},{"key":"2025101811104129000_12.8.e060301.21","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy601"},{"key":"2025101811104129000_12.8.e060301.22","doi-asserted-by":"crossref","unstructured":"van der Zee RP , Richel O , van Noesel CJM . Cancer risk stratification of anal intraepithelial neoplasia in HIV-positive men by validated methylation markers associated with progression to cancer. Clin Infect Dis 2020.","DOI":"10.1093\/cid\/ciaa397"},{"key":"2025101811104129000_12.8.e060301.23","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328359f255"},{"key":"2025101811104129000_12.8.e060301.24","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/bjd.18342","article-title":"Grading immunohistochemical markers p16\n                  INK4a\n                and HPV E4 identifies productive and transforming lesions caused by low- and high-risk HPV within high-grade anal squamous intraepithelial lesions","volume":"182","author":"Leeman","year":"2020","journal-title":"Br J Dermatol"},{"key":"2025101811104129000_12.8.e060301.25","doi-asserted-by":"crossref","unstructured":"van der Zee RP , Meijer C , Cuming T . Characterisation of anal intraepithelial neoplasia and anal cancer in HIV-positive men by immunohistochemical markers p16, Ki-67, HPV-E4 and DNA methylation markers. Int J Cancer 2021.","DOI":"10.1002\/ijc.33748"},{"key":"2025101811104129000_12.8.e060301.26","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2019.101661","article-title":"Prevalence and associations of larger burden of intra-anal high-grade squamous intraepithelial lesions at baseline in an Australian cohort of gay and bisexual men: the study of the prevention of anal cancer","volume":"64","author":"Templeton","year":"2020","journal-title":"Cancer Epidemiol"},{"key":"2025101811104129000_12.8.e060301.27","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000458"},{"key":"2025101811104129000_12.8.e060301.28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.16.2114"},{"key":"2025101811104129000_12.8.e060301.29","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2008.73"},{"key":"2025101811104129000_12.8.e060301.30","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01962-14"},{"key":"2025101811104129000_12.8.e060301.31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051114","article-title":"Improving the diagnostic accuracy of the PD-L1 test with image analysis and multiplex hybridization","volume":"12","author":"Humphries","year":"2020","journal-title":"Cancers"},{"key":"2025101811104129000_12.8.e060301.32","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2018-205271"},{"key":"2025101811104129000_12.8.e060301.33","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jval.2018.01.018","article-title":"Initial development and content validation of a health-related symptom index for persons either treated or monitored for anal high-grade squamous intraepithelial lesions","volume":"21","author":"Burkhalter","year":"2018","journal-title":"Value Health"},{"key":"2025101811104129000_12.8.e060301.34","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/cid\/ciaa397","article-title":"Cancer risk stratification of anal intraepithelial neoplasia in human immunodeficiency virus-positive men by validated methylation markers associated with progression to cancer","volume":"72","author":"van der Zee","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025101811104129000_12.8.e060301.35","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/QAD.0000000000002928","article-title":"Hpv vaccination to prevent recurrence of anal intraepithelial neoplasia in HIV+ MSM","volume":"35","author":"Gosens","year":"2021","journal-title":"AIDS"},{"key":"2025101811104129000_12.8.e060301.36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/infdis\/jiz614","article-title":"Anal squamous intraepithelial lesions (SILs) in human immunodeficiency virus-positive men who have sex with men: incidence and risk factors of sil and of progression and clearance of low-grade SILs","volume":"222","author":"Jongen","year":"2020","journal-title":"J Infect Dis"},{"key":"2025101811104129000_12.8.e060301.37","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/QAD.0000000000001639","article-title":"Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: is targeted screening possible?","volume":"31","author":"Siegenbeek van Heukelom","year":"2017","journal-title":"AIDS"},{"key":"2025101811104129000_12.8.e060301.38","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/DCR.0000000000001039","article-title":"Detection rate of high-grade squamous intraepithelial lesions as a quality assurance metric for high-resolution Anoscopy in HIV-positive men","volume":"61","author":"Siegenbeek van Heukelom","year":"2018","journal-title":"Dis Colon Rectum"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-060301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:10:51Z","timestamp":1760811051000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-060301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,3]]},"published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.1136\/bmjopen-2021-060301"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-060301","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}